Lange, T.; Krahl, R.; Grünhagen, U. vom; Al-Ali, H. K.; Schwarzer, A.; Uhle, R.; Spohn, C.; Lakner, V.; Assmann, M.; Junghanss, C.; Pfirrmann, M.; Gil, A.; Hehlmann, R.; Deininger, M. and Niederwieser, D.
(2017):
Imatinib (im) 400mg in patients with cml1st cp results in a higher molecular response rate at 6 months compared to im/hydroxyurea. Final results of the cml2004 study. Nct 02480608.
In: Haematologica, Vol. 102: pp. 729-730
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0390-6078 |
| Language: | English |
| Item ID: | 52006 |
| Date Deposited: | 14. Jun 2018, 09:48 |
| Last Modified: | 14. Jun 2018, 09:48 |
Actions (login required)
- View Item
